🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The combination of selective internal radiation therapy (SIRT) with immunot...
Status
Not Yet Recruiting
Location
Hôpital Paul Brousse - Radiology Department
Start Date
2025-06-01
Trial ID
NCT06971237
Treatments Being Tested
This is an open-label, multi-center, randomized phase II study comparing th...
Status
Terminated
Location
Georgetown University
Start Date
2020-11-30
Trial ID
NCT04541173
Treatments Being Tested
A single institution, single arm, two-cohort feasibility trial to evaluate ...
Status
Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2026-03-26
Trial ID
NCT07059494
Treatments Being Tested
The goal of this clinical trial is to compare the safety and efficacy of se...
Status
Recruiting
Location
Tuen Mun Hospital
Start Date
2024-04-01
Trial ID
NCT07293468
The purpose of this research is to compare progression free survival betwee...
Status
Recruiting
Location
Northwestern University
Start Date
2022-11-30
Trial ID
NCT05620771
Treatments Being Tested
The goal of this clinical trial is to learn if locoregional therapy and imm...
Status
Recruiting
Location
London Health Sciences Centre
Start Date
2024-12
Trial ID
NCT06725121
Treatments Being Tested
To observe and evaluate the efficacy and safety of selective internal radio...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-01
Trial ID
NCT06867432
Treatments Being Tested
This is a multi-national, phase II, parallel-arm, double-blind, placebo-con...
Status
Recruiting
Location
Beijing Tsinghua Changgung Hospital
Start Date
2022-10-26
Trial ID
NCT05377034
Treatments Being Tested
This study adopted a bidirectional cohort study design. On the one hand, th...
Status
Recruiting
Location
No. 777, Xitai Road, Chang'an District, Xi'an City, Shaanxi Province, China
Start Date
2022-02-09
Trial ID
NCT07610551
Treatments Being Tested